Sign in Register

Drug class

Mitomycin - systemic

"Mitomycin – systemic" is a route-specific administrative grouping rather than an independent pharmacologic class, referring to systemic formulations of the antineoplastic antibiotic and alkylating agent mitomycin. Read more about Mitomycin - systemic

15 drugs in this class 15 manufacturers

Related classes & indications

Alkylating AgentsOncology & immunomodulators · 192 prescription drugs Antirheumatic Agents (DMARDS, non-Biologic)Oncology & immunomodulators · 179 prescription drugs

Showing 10–15 of 15 drugs

Sort

MITOMYCIN

MITOMYCIN - SYSTEMIC · ADENOCARCINOMA OF PANCREAS ·+1

ARCHIS PHARMA L

MITOMYCIN

MITOMYCIN - SYSTEMIC · ADENOCARCINOMA OF PANCREAS ·+1

ARCHIS-NOVAPLUS

MITOMYCIN

MITOMYCIN - SYSTEMIC · ADENOCARCINOMA OF PANCREAS ·+1

MYLAN INSTITUTI

MITOMYCIN

MITOMYCIN - SYSTEMIC · ADENOCARCINOMA OF PANCREAS ·+1

WEST-WARD/HI-NO

MITOMYCIN

MITOMYCIN - SYSTEMIC · ADENOCARCINOMA OF PANCREAS ·+1

FRESENIUS KABI

MITOMYCIN

MITOMYCIN - SYSTEMIC · ADENOCARCINOMA OF PANCREAS ·+1

Hikma Pharmaceuticals USA

Filter & compare in the drug finder → Opens the drug finder with Mitomycin - systemic preselected. Add indication or manufacturer filters there.

About Mitomycin - systemic.

"Mitomycin – systemic" is a route-specific administrative grouping rather than an independent pharmacologic class, referring to systemic formulations of the antineoplastic antibiotic and alkylating agent mitomycin.

Functioning primarily as an intravenous chemotherapy, it undergoes intracellular enzymatic bioreduction to generate reactive intermediates that covalently cross-link DNA, inhibiting cellular replication and transcription.

Clinically, systemic mitomycin is utilized in combination antineoplastic regimens to treat gastrointestinal malignancies—most notably gastric and pancreatic adenocarcinomas, as well as squamous cell carcinoma of the anal canal—distinguishing these applications from localized intravesical, intracavitary, or ophthalmic formulations.

mims.com
"Mitomycin – systemic" is a route-specific administrative grouping rather than an independent pharmacologic class, referring to systemic formulations of the antineoplastic antibiotic and alkylating agent mitomycin Functioning primarily as an intravenous chemotherapy, it undergoes intracellular enzymatic bioreduction to generate reactive intermediates that covalently cross-link DNA, inhibiting cellular replication and transcription
drugs.com
"Mitomycin – systemic" is a route-specific administrative grouping rather than an independent pharmacologic class, referring to systemic formulations of the antineoplastic antibiotic and alkylating agent mitomycin Clinically, systemic mitomycin is utilized in combination antineoplastic regimens to treat gastrointestinal malignancies—most notably gastric and pancreatic adenocarcinomas, as well as squamous cell carcinoma of the anal canal—distinguishing these applications from localized intravesic...
oncodaily.com
Functioning primarily as an intravenous chemotherapy, it undergoes intracellular enzymatic bioreduction to generate reactive intermediates that covalently cross-link DNA, inhibiting cellular replication and transcription Clinically, systemic mitomycin is utilized in combination antineoplastic regimens to treat gastrointestinal malignancies—most notably gastric and pancreatic adenocarcinomas, as well as squamous cell carcinoma of the anal canal—distinguishing these applications from localized int...
nih.gov
Clinically, systemic mitomycin is utilized in combination antineoplastic regimens to treat gastrointestinal malignancies—most notably gastric and pancreatic adenocarcinomas, as well as squamous cell carcinoma of the anal canal—distinguishing these applications from localized intravesical, intracavitary, or ophthalmic formulations